MODIFICATION TO N/T RHEUMATOLOGY CONTROLS SL 1 & 2

Multi-analyte Controls, All Kinds (assayed)

DADE BEHRING, INC.

The following data is part of a premarket notification filed by Dade Behring, Inc. with the FDA for Modification To N/t Rheumatology Controls Sl 1 & 2.

Pre-market Notification Details

Device IDK021381
510k NumberK021381
Device Name:MODIFICATION TO N/T RHEUMATOLOGY CONTROLS SL 1 & 2
ClassificationMulti-analyte Controls, All Kinds (assayed)
Applicant DADE BEHRING, INC. 514 GBC DR. Newark,  DE  19702
ContactDonna A Wolf
CorrespondentDonna A Wolf
DADE BEHRING, INC. 514 GBC DR. Newark,  DE  19702
Product CodeJJY  
CFR Regulation Number862.1660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-05-01
Decision Date2002-06-10
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00842768007279 K021381 000
00842768007262 K021381 000
00630414287423 K021381 000
00630414287416 K021381 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.